Profile
Stephan Vagner is the founder of Ribonexus SAS.
He currently holds positions as a Research Director at Institut National de la Santé & de la Recherche Médicale and as a Member-Scientific Advisory Committee at Egenix, Inc.
Stephan Vagner active positions
| Companies | Position | Start |
|---|---|---|
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Corporate Officer/Principal | - |
Egenix, Inc.
 Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Director/Board Member | - |
Ribonexus SAS
 Ribonexus SAS Miscellaneous Commercial ServicesCommercial Services Ribonexus SAS is a French biotechnology company that specializes in developing oncology therapies. The company is based in Villejuif, France. The company was founded in 2021 by Stephan Vagner and is currently led by CEO Steven Powell. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Health Technology |
Ribonexus SAS
Ribonexus SAS Miscellaneous Commercial ServicesCommercial Services Ribonexus SAS is a French biotechnology company that specializes in developing oncology therapies. The company is based in Villejuif, France. The company was founded in 2021 by Stephan Vagner and is currently led by CEO Steven Powell. | Commercial Services |
- Stock Market
- Insiders
- Stephan Vagner
